Physician
Catarina Posada, MD PA
Catarina Posada, MD PA was paid $9.24M by Medicaid between Jan 2018 and Dec 2024, across 108 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 26% of everything it billed.
33Billing provider infoCATARINA POSADA, MD PA
WESLACO, TX 78599
WESLACO, TX 78599
33aNPI1134394539assigned 04/25/2008
33bProvider typePediatrics Physician
28Total paid$9.24M
24GClaims416,091
24DCodes billed108
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Texas
Rank by total paid#29 of 1,136
Median peer was paid$329K
This provider vs. median28×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 96 | $3K | |
| 2020 | 13,647 | $277K | |
| 2021 | 95,819 | $2.12M | |
| 2022 | 114,068 | $2.56M | |
| 2023 | 111,920 | $2.43M | |
| 2024incomplete | 80,541 | $1.85M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 26% | 68,801 | 55,921 | $2.44M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 16% | 29,538 | 26,578 | $1.47M |
| S9470 | Nutritional counseling, dietitian visit | 6.2% | 17,434 | 17,025 | $575K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 5.9% | 6,912 | 6,781 | $544K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 5.7% | 14,967 | 13,678 | $531K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 5.5% | 6,963 | 6,808 | $510K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 4.9% | 5,783 | 5,647 | $448K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 4.0% | 31,026 | 28,501 | $374K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 3.9% | 33,417 | 15,838 | $358K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3.6% | 4,515 | 4,401 | $334K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.6% | 11,610 | 9,490 | $238K |
| 99000 | 1.6% | 14,615 | 13,192 | $149K |
96 more codes
| 99429 | 1.6% | 5,129 | $147K | |
| 99050 | 1.4% | 9,185 | $131K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.1% | 12,975 | $104K |
| 92552 | <1% | 6,826 | $92K | |
| 87420 | <1% | 8,469 | $80K | |
| 99381 | <1% | 994 | $76K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 3,144 | $74K |
| 87400 | <1% | 6,396 | $72K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 2,567 | $72K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 9,718 | $55K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 613 | $44K |
| 90461 | <1% | 6,636 | $35K | |
| H0049 | Alcohol and/or drug screening | <1% | 3,615 | $32K |
| 92567 | <1% | 2,266 | $28K | |
| 87428 | <1% | 443 | $24K | |
| 99051 | <1% | 3,444 | $20K | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 2,602 | $19K |
| 87807 | <1% | 1,821 | $18K | |
| 83655 | <1% | 2,161 | $17K | |
| 17000 | <1% | 278 | $13K | |
| 92587 | <1% | 960 | $11K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 906 | $10K |
| 0071A | <1% | 259 | $10K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 971 | $10K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 818 | $9K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 106 | $9K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 354 | $8K |
| 0072A | <1% | 189 | $7K | |
| 99383 | <1% | 82 | $7K | |
| 82947 | <1% | 2,152 | $6K | |
| 99382 | <1% | 56 | $5K | |
| 81002 | <1% | 1,863 | $5K | |
| 96160 | <1% | 2,234 | $3K | |
| 90686 | <1% | 4,536 | $3K | |
| 80061 | Lipid panel | <1% | 283 | $3K |
| 85018 | <1% | 2,475 | $2K | |
| 99001 | <1% | 1,168 | $2K | |
| 84030 | <1% | 667 | $1K | |
| 0081A | <1% | 34 | $1K | |
| 86580 | <1% | 167 | $1K | |
| 0082A | <1% | 21 | $840.00 | |
| 0002A | <1% | 38 | $840.00 | |
| 94010 | <1% | 36 | $795.41 | |
| S8301 | Infection control supplies, not otherwise specified | <1% | 93 | $794.41 |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 13 | $735.03 |
| 94016 | <1% | 35 | $666.93 | |
| CP002 | <1% | 68 | $666.40 | |
| 0001A | <1% | 27 | $560.00 | |
| 69210 | <1% | 26 | $540.54 | |
| 90480 | <1% | 18 | $510.00 | |
| 90619 | <1% | 579 | $319.91 | |
| 90677 | <1% | 934 | $254.94 | |
| 69209 | <1% | 25 | $197.60 | |
| 81025 | <1% | 27 | $159.06 | |
| 94760 | <1% | 155 | $119.19 | |
| 81003 | <1% | 19 | $26.46 | |
| 90656 | <1% | 1,095 | $17.50 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 573 | $13.98 |
| 90651 | <1% | 1,718 | $0.81 | |
| 90671 | <1% | 815 | $0.78 | |
| G9716 | Bmi is documented as being outside of normal parameters, follow-up plan is not completed for documented medical reason | <1% | 2,211 | $0.52 |
| 97802 | <1% | 3,699 | $0.11 | |
| 36416 | 0% | 1,945 | $0.00 | |
| 90723 | 0% | 2,716 | $0.00 | |
| 90680 | 0% | 2,845 | $0.00 | |
| 90696 | 0% | 945 | $0.00 | |
| S9451 | Exercise classes, non-physician provider, per session | 0% | 7,938 | $0.00 |
| 90716 | 0% | 353 | $0.00 | |
| 90647 | 0% | 3,673 | $0.00 | |
| 96127 | 0% | 4,120 | $0.00 | |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | 0% | 44 | $0.00 |
| 91307 | 0% | 500 | $0.00 | |
| 90698 | 0% | 337 | $0.00 | |
| J8540 | Dexamethasone, oral, 0.25 mg | 0% | 121 | $0.00 |
| 90657 | 0% | 52 | $0.00 | |
| 90697 | 0% | 99 | $0.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 14 | $0.00 |
| 82962 | 0% | 13 | $0.00 | |
| 99401 | 0% | 511 | $0.00 | |
| 90715 | 0% | 991 | $0.00 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 3,699 | $0.00 |
| 90633 | 0% | 2,272 | $0.00 | |
| 90707 | 0% | 334 | $0.00 | |
| 90734 | 0% | 988 | $0.00 | |
| 90670 | 0% | 2,580 | $0.00 | |
| 91300 | 0% | 145 | $0.00 | |
| 90710 | 0% | 1,688 | $0.00 | |
| 99173 | 0% | 7,942 | $0.00 | |
| 90700 | 0% | 1,114 | $0.00 | |
| 90658 | 0% | 356 | $0.00 | |
| 91308 | 0% | 63 | $0.00 | |
| 91321 | 0% | 17 | $0.00 | |
| 90655 | 0% | 156 | $0.00 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 0% | 60 | $0.00 |
| 99188 | 0% | 53 | $0.00 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 39 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPOSADA, CATARINA (OWNER)